<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dixit S</submitter><funding>NIGMS NIH HHS</funding><pagination>1311-21</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4119847</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(6)</volume><pubmed_abstract>PLA-PEG [poly(lactic acid)-poly (ethylene glycol)], a biodegradable copolymer, is underexploited for vaccine delivery although it exhibits enhanced biocompatibility and slow release immune-potentiating properties. We document here successful encapsulation of M278, a Chlamydia trachomatis MOMP (major outer-membrane protein) peptide, within PLA-PEG nanoparticles by size (~73-100nm), zeta potential (-16 mV), smooth morphology, encapsulation efficiency (~60%), slow release pattern, and non-toxicity to macrophages. Immunization of mice with encapsulated M278 elicited higher M278-specific T-cell cytokines [Th1 (IFN-γ, IL-2), Th17 (IL-17)] and antibodies [Th1 (IgG2a), Th2 (IgG1, IgG2b)] compared to bare M278. Encapsulated-M278 mouse serum inhibited Chlamydia infectivity of macrophages, with a con</pubmed_abstract><journal>Nanomedicine : nanotechnology, biology, and medicine</journal><pubmed_title>Poly(lactic acid)-poly(ethylene glycol) nanoparticles provide sustained delivery of a Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in mice.</pubmed_title><pmcid>PMC4119847</pmcid><funding_grant_id>1R25GM106995-01</funding_grant_id><funding_grant_id>R25 GM106995</funding_grant_id><pubmed_authors>Dixit S</pubmed_authors><pubmed_authors>Yilma AN</pubmed_authors><pubmed_authors>Dennis VA</pubmed_authors><pubmed_authors>Singh SR</pubmed_authors><pubmed_authors>Agee RD</pubmed_authors><pubmed_authors>Taha M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Poly(lactic acid)-poly(ethylene glycol) nanoparticles provide sustained delivery of a Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in mice.</name><description>PLA-PEG [poly(lactic acid)-poly (ethylene glycol)], a biodegradable copolymer, is underexploited for vaccine delivery although it exhibits enhanced biocompatibility and slow release immune-potentiating properties. We document here successful encapsulation of M278, a Chlamydia trachomatis MOMP (major outer-membrane protein) peptide, within PLA-PEG nanoparticles by size (~73-100nm), zeta potential (-16 mV), smooth morphology, encapsulation efficiency (~60%), slow release pattern, and non-toxicity to macrophages. Immunization of mice with encapsulated M278 elicited higher M278-specific T-cell cytokines [Th1 (IFN-γ, IL-2), Th17 (IL-17)] and antibodies [Th1 (IgG2a), Th2 (IgG1, IgG2b)] compared to bare M278. Encapsulated-M278 mouse serum inhibited Chlamydia infectivity of macrophages, with a con</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Aug</publication><modification>2025-04-19T04:17:31.228Z</modification><creation>2019-03-27T01:33:17Z</creation></dates><accession>S-EPMC4119847</accession><cross_references><pubmed>24602605</pubmed><doi>10.1016/j.nano.2014.02.009</doi></cross_references></HashMap>